A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol

Autor: Gerson M. Struik, Jeremy Godart, Gerda M. Verduijn, Inger-Karine Kolkman-Deurloo, Kim C. de Vries, Raymond de Boer, Linetta B. Koppert, Erwin Birnie, Ali Ghandi, Taco M. Klem, Jean-Philippe Pignol

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-8 (2018)

Abstract Background Accelerated partial breast irradiation (APBI) is a treatment option for selected early stage breast cancer patients. Some APBI techniques lead to skin toxicity with the skin dose as main risk factor. We hypothesize that a spacer i

Externí odkaz: https://doaj.org/article/736eb42cda4546cfbfa2d3164cb380ad

Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis

Autor: Eline D. Hessen, Laurens D. van Buuren, Jasper A. Nijkamp, Kim C. de Vries, Wai Kong Mok, Luc Dewit, Anke M. van Mourik, Alejandro Berlin, Uulke A. van der Heide, Gerben R. Borst

Publikováno v: Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 23-28 (2017)

Introduction: Linac-based stereotactic radiosurgery (SRS) for brain metastases may be influenced by the time interval between treatment preparation and delivery, related to risk of anatomical changes. We studied tumor position shifts and its relation

Externí odkaz: https://doaj.org/article/34ece1badc5a4eb49cc668315cf50d3c

Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer

Autor: M. Milder, Marta K. Giżyńska, Ben J.M. Heijmen, Wilhelm den Toom, Linda Rossi, Joost J. Nuyttens, Kim C. de Vries

Publikováno v: Journal of Applied Clinical Medical Physics, 22(3), 35-47. American Institute of Physics (AIP)
Journal of Applied Clinical Medical Physics

Recently, VOLO™ was introduced as a new optimizer for CyberKnife® planning. In this study, we investigated possibilities to improve treatment plans for MLC-based prostate SBRT with enhanced peripheral zone dose while sparing the urethra, and centr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a08ed04612c61318cf77bf34ee6b6f
https://doi.org/10.1002/acm2.13172

Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study

Autor: Maaike Schippers, Rebecca K. Stellato, Paulien G Westhoff, Anna K.L. Reyners, Francisca Ong, Ruud Wiggenraad, Angela van Baardwijk, Alexander de Graeff, G. Wester, Bonnie Bakri, Ilse de Pree, Kim C. de Vries, Tom Budiharto, Yvette M. van der Linden, Lieneke van Veelen

Publikováno v: International Journal of Radiation Oncology Biology Physics, 108(3), 546-553. Elsevier Science
International Journal of Radiation Oncology Biology Physics, 108(3), 546-553. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 108, 546-553
International Journal of Radiation Oncology-Biology-Physics, 108(3), 546-553. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 108, 3, pp. 546-553
International Journal of Radiation Oncology, Biology, Physics, 108(3), 546-553. ELSEVIER SCIENCE INC

Contains fulltext : 225317.pdf (Publisher’s version ) (Open Access) PURPOSE: After radiation therapy for painful bone metastases, up to 44% of patients report a pain flare (PF). Our study compared 2 dose schedules of dexamethasone versus placebo to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939145336265f9b5ed16b9faf3501890
https://cris.maastrichtuniversity.nl/en/publications/f87adc28-76b2-4466-a1cc-09aa66767e94

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

Autor: Lukas J.A. Stalpers, Charles G.H.J. Niël, Hanneke Vos-Westerman, Johanna G. H. van Nes, Joost J. Nuyttens, Peter Koper, Tom Rozema, Jaap D. Zindler, Kim C. de Vries, Paul M. Jeene, Joost J.C. Verhoeff, Ilona Schmeets, Johannes J.M. Kwakman, Pètra M. Braam, Yvette M. van der Linden, Stefan Hutschemaekers, G. Wester

Publikováno v: Acta Oncologica, 57, 637-643
Acta Oncologica, 57, 5, pp. 637-643
Acta Oncologica, 57(5), 637-643. Informa Healthcare
Acta Oncologica, 57, 637. Informa Healthcare
Acta Oncologica, 57(5), 637-643
Jeene, P M, de Vries, K C, van Nes, J G H, Kwakman, J J M, Wester, G, Rozema, T, Braam, P M, Zindler, J D, Koper, P, Nuyttens, J J, Vos-Westerman, H A, Schmeets, I, Niël, C G H J, Hutschemaekers, S, van der Linden, Y M, Verhoeff, J J C & Stalpers, L J A 2018, ' Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014 ', Acta Oncologica, vol. 57, no. 5, pp. 637-643 . https://doi.org/10.1080/0284186X.2017.1418534
Acta oncologica (Stockholm, Sweden), 57(5), 637-643. Informa Healthcare
Acta Oncologica, 57(5), 637-643. Routledge/Taylor & Francis Group

Background: Whole brain radiotherapy (WBRT) is considered standard of care for patients with multiple brain metastases or unfit for radical treatment modalities. Recent studies raised discussion about the expected survival after WBRT. Therefore, we a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beae62b1212fd0f12b93f463c2e215a3
https://doi.org/10.1080/0284186x.2017.1418534